The potential of histone deacetylase inhibitors for the treatment of multiple myeloma

被引：11
|
作者：
Prince, H. Miles [1 ,2 ]
Bishton, Mark [1 ,2 ]
Harrison, Simon [1 ,2 ]
机构：
[1] Peter MacCallum Canc Ctr, Haematol Serv, Melbourne, Vic, Australia
[2] Univ Melbourne, Parkville, Vic 3052, Australia
来源：
LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 03期
关键词：
myeloma; neoplasia; histone; deacetylase;
D O I：
10.1080/10428190801950058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Preclinical evidence supports the investigation of histone deacetylase inhibitors for the treatment of myeloma. Results from early studies demonstrate clinical activity and further studies investigating combination strategies should be explored.
引用
收藏
页码：385 / 387
页数：3
相关论文
共 50 条
  • [1] Histone deacetylase inhibitors in the treatment for multiple myeloma
    Hideshima, Teru
    Anderson, Kenneth C.
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 324 - 332
  • [2] Histone deacetylase inhibitors in the treatment for multiple myeloma
    Teru Hideshima
    Kenneth C. Anderson
    [J]. International Journal of Hematology, 2013, 97 : 324 - 332
  • [3] Histone deacetylase inhibitors in multiple myeloma
    Deleu, Sarah
    Menu, Eline
    Van Valckenborgh, Els
    Van Camp, Ben
    Fraczek, Joanna
    Broek, Isabelle Vande
    Rogiers, Vera
    Vanderkerken, Karin
    [J]. HEMATOLOGY REPORTS, 2009, 1 (01) : 46 - 55
  • [4] Histone deacetylase inhibitors in multiple myeloma
    Pratt, Guy
    [J]. LANCET ONCOLOGY, 2013, 14 (11): : 1038 - 1039
  • [5] New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
    Cea, Michele
    Cagnetta, Antonia
    Gobbi, Marco
    Patrone, Franco
    Richardson, Paul G.
    Hideshima, Teru
    Anderson, Kenneth C.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (04) : 734 - 744
  • [6] Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
    Zain, Jasmine
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (03) : 671 - +
  • [7] Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
    Stiff, Andrew
    Caserta, Enrico
    Sborov, Douglas W.
    Nuovo, Gerard J.
    Mo, Xiaokui
    Schlotter, Sarah Y.
    Canella, Alessandro
    Smith, Emily
    Badway, Joseph
    Old, Matthew
    Jaime-Ramirez, Alena Cristina
    Yan, Pearlly
    Benson, Don M.
    Byrd, John C.
    Baiocchi, Robert
    Kaur, Balveen
    Hofmeister, Craig C.
    Pichiorri, Flavia
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) : 830 - 841
  • [8] Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
    T Hideshima
    F Cottini
    H Ohguchi
    J Jakubikova
    G Gorgun
    N Mimura
    Y-T Tai
    N C Munshi
    P G Richardson
    K C Anderson
    [J]. Blood Cancer Journal, 2015, 5 : e312 - e312
  • [9] Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
    Hideshima, T.
    Cottini, F.
    Ohguchi, H.
    Jakubikova, J.
    Gorgun, G.
    Mimura, N.
    Tai, Y-T
    Munshi, N. C.
    Richardson, P. G.
    Anderson, K. C.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e312 - e312
  • [10] Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
    Tandon, Nidhi
    Ramakrishnan, Vijay
    Kumar, Shaji K.
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 35 - 44
12345